SNP Combos in Three CYP450 Genes Affect Psychotropic Rx Response, Genomas Finds

Patients with major depressive disorder who carry combinations of the CYP2C9, CYP2C19, and CYP2D6 genes have limited ability to metabolize psychotropic medications, among them antipsychotics, antidepressants, anticonvulsants, and one stimulant, according to a recent study performed by researchers at Genomas and Hartford Hospital.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register quickly here.